Lung Cancer Efficacy and Safety of Pemigatinib in Pan-Cancer have an Acceptable Safety Profile: FIGHT-101 Apr 17, 2023
Lung Cancer Neoadjuvant Sintilimab Plus Chemotherapy: Two Cycles vs. Three for Resectable NSCLC Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Comparing Perioperative Nivolumab vs Observation in RCC Patients Undergoing Nephrectomy: PROSPER Phase 3 Study Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Phase 2 LITESPARK-004: Belzutifan, a HIF-2α Inhibitor, for VHL Disease-Associated Neoplasms Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Telaglenastat Plus Cabozantinib vs. Placebo Plus Cabozantinib in Advanced RCC Patients:CANTATA Phase 2 Trial Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Phase III NKTR-214: BEMPEG Results: BEMPEG and NIVO vs. Sunitinib or Cabozantinib in RCC Apr 17, 2023
Genitourinary Cancer,RCC (Renal Cell Carcinoma) Comparing Adjuvant Atezolizumab vs. Placebo in RCC Patients at High Risk of Recurrence: IMmotion010 Phase 3 Trial Apr 17, 2023
